Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Debrisoquine oxidation polymorphism in patients with chronic inflammatory bowel disease.

Annals of medicine - 1 Oct 1995

Ladero J M, Benítez J, Serrano M, García-Paredes J, Diaz-Rubio M

Abstract excerpt

Polymorphic hydroxylation of debrisoquine (DBQ) is a Mendelian genetic trait related to the risk of suffering some spontaneous disorders. To elucidate whether such a relation exists between this polymorphism and chronic inflammatory bowel disease (CIBD), 67 (39 males) patients with ulcerative colitis (UC), 52 (35 males) patients with Crohn's disease (CD) and 837 healthy controls (391 males) received 10 mg...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colitis, Ulcerative
Share to Crohn Disease
Share to Debrisoquin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Oxidation-Reduction

Share to Phenotype

Share to Polymorphism, Genetic

Share to Risk Factors

Source

Identifiers

PMID: 8541031
DOI: 10.3109/07853899509002468

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Debrisoquine oxidation polymorphism in patients with chronic inflammatory bowel disease.PMID 8541031Read ↗

Genetic polymorphisms of CYP2D6 oxidation in patients with inflammatory bowel disease.Semantic proximity Read ↗

Altered distribution of the debrisoquine oxidative phenotypes in children with type 1 diabetes mellitus.Semantic proximity Read ↗

Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation CapacitySemantic proximity Read ↗

Oxidative polymorphism of debrisoquine is not related to the risk of Alzheimer's disease.Semantic proximity Read ↗

Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population.Semantic proximity Read ↗

Polymorphic debrisoquin metabolism in a Turkish population.Semantic proximity Read ↗

Oxidation phenotyping with debrisoquine in Germany (East).Semantic proximity Read ↗

Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population.Semantic proximity Read ↗

Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.Semantic proximity Read ↗

Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients.Semantic proximity Read ↗

Determination of debrisoquine oxidation phenotype in healthy volunteers during phase I trials.Semantic proximity Read ↗

Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.